1 / 12

GLYCOBIOLOGY MARKET ANALYSIS | Coherent Market Insights

<br>Read here the latest updates on the GLYCOBIOLOGY MARKET ANALYSIS published by CMI team.<br>

adwaitcoherent
Télécharger la présentation

GLYCOBIOLOGY MARKET ANALYSIS | Coherent Market Insights

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Coherent Marketing Insights https://www.coherentmarketinsights.com/ Market Research & Business Consulting Services Covid-19 Impact Tracker

  2. GLYCOBIOLOGY MARKET ANALYSIS Glycobiology Market, By Product Type (Instruments, Enzymes, Consumables, Reagents & Kits), By Enzymes (Galactosidase (Fucosidases, Chitinases, Acetylgalactosaminidase, Heparinase, PNGase F, Others), GlcNAc Transferases (Acetylglucosaminyltransferase, Exostosin, Others), Fucosyltransferases, GalNAc Transferases, Galactosyl Transferases, Glucuronosyltransferases, Glucosyltransferases, Pentosyltransferases, Carbohydrate Kinases, Neuraminidases, Sialyltransferases, Others), By Application (Drug Discovery and Development Diagnostic Applications (Oncology, Immunology, Others), Industrial Application Therapeutic Application (Oncology, Immunology, Others), Others), By End User (Biopharmaceutical Companies, Research Laboratories, Hospitals, Diagnostic Centers, Contract Research Organizations, Biotechnology Industries, Academic Institutes, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

  3. The term glycobiology is a branch of biology that deals with study of structure, function, and biosynthesis of saccharides (carbohydrates and carbohydrates containing molecules). Glycoconjugates is the general classification for carbohydrates covalently linked with other chemical species such as proteins, peptides, lipids and saccharides. Glycoconjugates and polysaccharides play a vital structural role in connective tissues. Global Glycobiology Market: Drivers Glycans impact tumor proliferation, hematogenous metastasis, invasion and angiogenesis. Therefore, increasing prevalence of cancer is expected to propel growth of the global glycobiology market over the forecast period. For instance, according to the World Health Organization, around 18.1 million new cases and 9.6 million deaths were registered due to cancer worldwide in 2018. Moreover, high incidence of HIV/AIDS is also expected to aid in growth of the market. For instance, according to Joint United Nations Program on HIV/AIDS, 37.9 million people globally were living with HIV at the end of 2018.

  4. Global Glycobiology Market: Restraints Complex structure of glycans is expected to hinder growth of the global glycobiology market. Unlike DNA or proteins, glycans do not have linear structure. Conventional sequence comparison methods cannot be applied directly to glycan comparison as structure and mechanism of glycans are completely different from DNA or proteins, which makes it more complex for analyzing. DNA or proteins have template sequences to synthesize primary structure, which are uniquely identified by template sequences. However, glycans do not have a template structure. Structure of glycan is determined by substrate specificity of glycosyl-transferases. Moreover, high costs of spectrometry and high performance liquid chromatography are also expected to limit growth of the market.

  5. Global Glycobiology Market: Opportunities R&D in glycans is expected to offer lucrative growth opportunities for players in the global glycobiology market. For instance, in February 2020, researchers from University of Minho, Portugal, reported development of a neurocompatible strategy to image temporal distribution of glycoproteins during neuronal development using Cu-free click chemistry. Moreover, increasing focus on manufacturing anti-cancer drugs is also expected to aid in growth of the market. For instance, in January 2020, researchers from Universidade do Porto, Portugal, reported assessment of the role of O-glycosylation using glycoengineered gastric cancer models in the detection of CD44v9 – a major protein splice variant isoforms expressed in human gastrointestinal cancer cells—by monoclonal antibodies. Enzymes segment in the global glycobiology market was valued at US$ 487.1 Mn in 2019 and is expected to reach US$ 1,371.0 Mn by 2027 at a CAGR of 13.6% during the forecast period.

  6. Market Trends/Key Takeaways Increasing adoption of viscosupplementation and facial aesthetic using hyaluronic acid is aiding growth of the market. Hyaluronan, a natural occurring glycosaminogen, is used in viscosupplementation and tissue fillers for volume restoration in facial rejuvenation. Replacement of conventional glycoanalysis approaches with advanced techniques is also boosting growth of the market. Conventional methods for analysis of glycoforms in complex glycoproteins such as gel electrophoresis and elemental analysis are rapidly getting replaced by new approaches such as nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS).

  7. Global Glycobiology Market: Competitive Landscape Major players operating in the global glycobiology market include, Merck KGaA, Bio-Techne Corporation, Bruker Corporation, Thermo Fisher Scientific, Inc., Shimadzu Corporation, Plexera Bioscience LLC, New England Biolabs Inc., Agilent Technologies, Inc., and ProZyme, Inc. Global Glycobiology Market: Key Developments Major players in the market are focused on adopting various marketing strategies to expand their customer base. For instance, in February 2020, New England Biolabs demonstrated its next generation sequencing portfolio at 2020 Advances in Genome Biology and Technology (AGBT) General Meeting, held in the U.S. Players in the market are also focused on adopting partnership strategies to expand their product portfolio. For instance, in November 2019, MOBILion Systems, Inc. partnered with researchers at the University of Georgia, for R&D in glycans and glycoproteins.

  8. Request Sample Report Request Customization Download PDF Brochure Talk to Analyst Referance: https://www.coherentmarketinsights.com/market-insight/glycobiology-market-3639

  9. About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. What We Provide:Customized Market Research AnalysisIndustry Analysis ServicesBusiness Consulting ServicesLong Term Engagement ModelCountry Specific Analysis

  10. Contact Us Mr. Shah Coherent Market Insights Pvt. LTD.Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154, U.S.Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com

  11. Thank You Kindly Follow CMI Social Media Profiles for the latest Company Updates. Facebook Linkedin Twitter https://www.coherentmarketinsights.com/

More Related